US Patent Issued to University of Jeddah, King Abdulaziz University, Helwan University on March 25 for "Aryl-1,2,3-triazole compounds, pharmaceutical composition thereof and method for treatment of breast cancer" (Saudi Arabia, Egyptian Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,321, issued on March 25, was assigned to University of Jeddah (Jeddah, Saudi Arabia), King Abdulaziz University (Cairo) and Helwan University (Cairo).

"Aryl-1,2,3-triazole compounds, pharmaceutical composition thereof and method for treatment of breast cancer" was invented by Roaa M. Alreemi (Jeddah, Saudi Arabia), Hind A. Alkhatabi (Jeddah, Saudi Arabia), Mohammed A. Baradwan (Jeddah, Saudi Arabia), Abdelsattar M. Omar (Jeddah, Saudi Arabia), Moustafa E. El-Araby (Cairo), Yara E. Mansour (Cairo), Samar S. Fatahala (Cairo), Ahmed M. Said (Cairo) and Shahenda Mahgoub (Cairo).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds belonging to the gr...